415 Comparison of two Phase II trials evaluating three dosing regimens of fulvestrant in Japanese vs non-Japanese postmenopausal women with advanced breast cancer (FINDER1 and FINDER2)

H.Iwata; S.Ohno; Y.Rai; N.Yamamoto; M.Yoshida; H.Iwase; J.Lindemann; M.Macpherson; S.Noguchi; K.I.Pritchard

首页> 外文期刊>European Journal of Cancer Supplements >415 Comparison of two Phase II trials evaluating three dosing regimens of fulvestrant in Japanese vs non-Japanese postmenopausal women with advanced breast cancer (FINDER1 and FINDER2)

【24h】

415 Comparison of two Phase II trials evaluating three dosing regimens of fulvestrant in Japanese vs non-Japanese postmenopausal women with advanced breast cancer (FINDER1 and FINDER2)

机译：415在日本和非日本绝经后晚期乳腺癌患者（FINDER1和FINDER2）中评估氟维司群的三种给药方案的两项II期试验的比较

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2010年第3期|共1页
作者
H.Iwata; S.Ohno; Y.Rai; N.Yamamoto; M.Yoshida; H.Iwase; J.Lindemann; M.Macpherson; S.Noguchi; K.I.Pritchard;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
专利

1. Three dose regimens of fulvestrant in postmenopausal Japanese women with advanced breast cancer: results from a double-blind, phase II comparative study (FINDER1). [J] . Ohno S, Rai Y, Iwata H, Annals of oncology: official journal of the European Society for Medical Oncology . 2010,第12期

机译：绝经后日本晚期乳腺癌妇女的三剂氟维司群治疗方案：一项双盲，II期比较研究（FINDER1）的结果。
2. Three dose regimens of fulvestrant in postmenopausal Japanese women with advanced breast cancer: results from a double-blind,n phase II comparative study (FINDER1) [J] . S. Noguchi Annals of Oncology . 2010,第12期

机译：绝经后日本晚期乳腺癌妇女的三剂氟维司群治疗方案：一项双盲n期II期比较研究的结果（FINDER1）
3. Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2). [J] . Pritchard KI, Rolski J, Papai Z, Breast cancer research and treatment. . 2010,第2期

机译：一项II期研究的结果比较了绝经后患有晚期乳腺癌的女性中氟维司群的三种给药方案（FINDER2）。
4. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
5. Analysis of quality of life data from a clinical trial in patients with advanced breast cancer with a comparison of different statistical approaches. [D] . Liu, Jianhua. 2002

机译：通过比较不同统计方法对晚期乳腺癌患者的临床试验的生活质量数据进行分析。
6. Endocrine Therapy With or Without Inhibition of Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2: A Randomized Double-Blind Placebo-Controlled Phase III Trial of Fulvestrant With or Without Lapatinib for Postmenopausal Women With Hormone Receptor–Positive Advanced Breast Cancer—CALGB 40302 (Alliance) [O] . Harold J. Burstein, Constance T. Cirrincione, William T. Barry, -1

机译：有或没有抑制表皮生长因子受体和人表皮生长因子受体的内分泌治疗2：接受或不接受拉帕替尼的氟维沙坦的随机双盲安慰剂对照的Ⅲ期临床试验用于绝经后激素受体阳性的晚期乳腺癌女性。 CALGB 40302（联盟）
7. Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00) [O] . Perey, L., Paridaens, R., Hawle, H., 2017

机译：氟维司群对绝经后晚期乳腺癌和原发性或获得性对芳香化酶抑制剂耐药的妇女的临床获益：瑞士临床癌症研究试验第二阶段的最终结果（SAKK 21/00）

415 Comparison of two Phase II trials evaluating three dosing regimens of fulvestrant in Japanese vs non-Japanese postmenopausal women with advanced breast cancer (FINDER1 and FINDER2)

著录项

相似文献

相关主题

期刊订阅